Critical signaling pathways in osteoclast differentiation and bone resorption: mechanisms and therapeutic implications for periprosthetic osteolysis
Authors:
Top Cited Papers
Open Access
- 26 August 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 13, 1639430
Abstract
Bone homeostasis is dynamically regulated by the balance between osteoclast-mediated bone resorption and osteoblast-driven bone formation. Periprosthetic osteolysis (PPO), a major complication following joint arthroplasty, occurs when excessive bone resorption surpasses formation, leading to implant loosening and failure. Emerging evidence highlights the pivotal roles of the RANKL/RANK/OPG axis, nuclear factor-κB (NF-κB) signaling, and mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) cascades in osteoclast differentiation and pathological bone resorption. This review systematically explores the molecular mechanisms by which these pathways regulate osteoclastogenesis and their pathological contributions to PPO. Specifically, we analyze how wear particle-induced inflammation reprograms these signaling networks to exacerbate osteolytic activity. Furthermore, we discuss potential therapeutic strategies targeting these pathways, including pharmacological inhibitors, gene therapy, and dual-target interventions, to restore bone homeostasis. By integrating recent advances in osteoimmunology and translational research, this work provides a comprehensive framework for understanding PPO pathogenesis and developing precision therapies.Keywords
This publication has 238 references indexed in Scilit:
- Interleukin‐4 repairs wear particle induced osteolysis by modulating macrophage polarization and bone turnoverJournal of Biomedical Materials Research Part A, 2020
- Glucocorticoids Disrupt Skeletal Angiogenesis Through Transrepression of NF-κB–Mediated Preosteoclast Pdgfb Transcription in Young MiceJournal of Bone and Mineral Research, 2020
- Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease BurdenJournal of Bone and Mineral Research, 2018
- TRAF6 Mediates Suppression of Osteoclastogenesis and Prevention of Ovariectomy-Induced Bone Loss by a Novel PrenylflavonoidJournal of Bone and Mineral Research, 2016
- Correlations between macrophage polarizing cytokines, inflammatory mediators, osteoclast activity, and toll‐like receptors in tissues around aseptically loosened hip implantsJournal of Biomedical Materials Research Part A, 2016
- Osteocyte Apoptosis Caused by Hindlimb Unloading is Required to Trigger Osteocyte RANKL Production and Subsequent Resorption of Cortical and Trabecular Bone in Mice FemursJournal of Bone and Mineral Research, 2016
- Macrophages—Key cells in the response to wear debris from joint replacementsJournal of Biomedical Materials Research Part A, 2013
- Osteopetrosis rescue upon RANKL administration to Rankl−/− mice: A new therapy for human RANKL-dependent AROJournal of Bone and Mineral Research, 2012
- The amazing osteocyteJournal of Bone and Mineral Research, 2010
- Osteoblasts and osteocytes express MMP2 and ‐8 and TIMP1, ‐2, and ‐3 along with extracellular matrix molecules during appositional bone formationThe Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 2004